| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/19/2005 | CN1565443A Daphnetin cyclodextrin clathrate compound, formulation and its preparation method |
| 01/19/2005 | CN1565437A Verapamil hydrochloric acid drop pill and its preparation method |
| 01/19/2005 | CN1565433A Hypocrellin water-soluble nanogranule and its uses |
| 01/19/2005 | CN1565430A Allicin cyclodextrin clathrate compound, formulation and its preparation method |
| 01/19/2005 | CN1565429A Instant oral film preparation and its preparation method |
| 01/19/2005 | CN1565428A Chitosan microcapsule and its preparation method and uses |
| 01/19/2005 | CN1565427A Gastric 5-fluorouracil double slow release tablet of float and stay type for curing gastric cancer |
| 01/19/2005 | CN1565426A Formula containing water-soluble medicine slow release tablet and its preparation method |
| 01/19/2005 | CN1565425A Rapid oral cavity disintegration tablet and its preparation method |
| 01/19/2005 | CN1565420A Oral nano nourishing emulsion and its preparation method |
| 01/19/2005 | CN1185257C Glucagon insulinotropic complexes, compositions and methods |
| 01/19/2005 | CN1185253C Neoglycoproteins |
| 01/19/2005 | CN1185014C Biodegradation type introducing agent of hardly water-soluble steroid, nonsteroid anti-inflammatory medicine, and its prepn. method |
| 01/19/2005 | CN1185013C 赋形剂 Excipient |
| 01/19/2005 | CN1185009C Eye preparation |
| 01/19/2005 | CN1184971C Pharmaceutical combination preparations |
| 01/19/2005 | CN1184962C Sertraline oral condensate |
| 01/19/2005 | CN1184959C Compositions containing ascorbic acid and pectin |
| 01/19/2005 | CN1184958C Erythropoietin Liposomal dispersion |
| 01/19/2005 | CN1184903C Method for stabilizing liquid nutritional products and products so stabilized |
| 01/18/2005 | US6844459 Pharmaceutical Composition |
| 01/18/2005 | US6844364 Stabilization of retinoid compounds |
| 01/18/2005 | US6844329 Synthetic oligo- and polysaccharides exhibiting at least one covalent bond with biotin or a biotin derivative and having the anticoagulant and antithrombotic pharmacological activities of heparin |
| 01/18/2005 | US6844319 Targeting Hepatic Stellate Cells (HSC) involved in sclerotic and/or fibrotic diseases with carrier linked to amino acid sequence SRNLIDC |
| 01/18/2005 | US6844318 Peptidase-cleavable, targeted antineoplastic drugs and their therapeutic use |
| 01/18/2005 | US6844317 Methods for oxygen transport comprising a high oxygen affinity modified hemoglobin |
| 01/18/2005 | US6844313 With protein or phosphoglyceride as aqueous solution; in vitro fertilization |
| 01/18/2005 | US6844306 Water-soluble, chlorhexidine-containing compositions and use thereof |
| 01/18/2005 | US6844172 Amylose products as matrix former for programmed release systems, process for preparing these amylose products, and process for making programmed release systems |
| 01/18/2005 | US6844153 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 01/18/2005 | US6844009 Media in the form of complex dispersions, method for preparing same and uses |
| 01/18/2005 | US6844008 Tablet composition |
| 01/18/2005 | US6844004 Topical formulations of natamycin/pimaricin |
| 01/18/2005 | US6844001 Adjuvants and copolymer compositions |
| 01/18/2005 | US6843998 Methods and compositions for the treatment of pancreatitis |
| 01/18/2005 | US6843980 Methods for using annexin for detecting cell death in vivo and treating associated conditions |
| 01/18/2005 | US6843961 Deactivation pathogens; using riboflavin sensitizers; exposure to light source |
| 01/16/2005 | CA2465681A1 The use of conjugated linoleic acid or derivative thereof for the treatment of the common cold |
| 01/15/2005 | CA2464831A1 Stable non-dihydrate azithromycin oral suspensions |
| 01/13/2005 | WO2005003775A2 Glycoconjugates and their use as potential vaccines against infection by shigella flexneri |
| 01/13/2005 | WO2005003722A2 Nanotube structures having a surfactant bilayer inner wall coating |
| 01/13/2005 | WO2005003296A2 Albumin fusion proteins |
| 01/13/2005 | WO2005003295A2 Methods and compositions for maturing dendritic cells utilizing inosine-containing compounds |
| 01/13/2005 | WO2005003154A2 Compositions and methods for the diagnosis and treatment of tumor |
| 01/13/2005 | WO2005003032A1 Zeolites for delivery of nitric oxide |
| 01/13/2005 | WO2005002643A2 Method and products for delivering biological molecules to cells using multicomponent nanostructures |
| 01/13/2005 | WO2005002627A2 Conjugated complement cascade inhibitors |
| 01/13/2005 | WO2005002626A2 Therapeutic phosphonate compounds |
| 01/13/2005 | WO2005002625A2 In-situ gelling drug delivery system |
| 01/13/2005 | WO2005002615A1 Liquid, aqueous pharmaceutical composition of factor vii polypeptides |
| 01/13/2005 | WO2005002581A1 Use of osmolytes obtained from extremophilic bacteria for producing medicaments for the external treatment of neurodermatitis |
| 01/13/2005 | WO2005002554A2 A method of promoting sleep using topical administration of vasoactive agents |
| 01/13/2005 | WO2005002548A1 Stable pharmaceutical compositions of 2-aza-bicyclo[3.3.0]-octane-3-carboxylic acid derivatives |
| 01/13/2005 | WO2005002547A1 Matrix adjuvants and the drop pills prepared with them |
| 01/13/2005 | WO2005002544A2 Stabilized particle dispersions containing nanoparticles |
| 01/13/2005 | WO2005002516A2 Leukocyte internalized peptide-drug conjugates |
| 01/13/2005 | WO2005002510A2 Deployable multifunctional hemostatic agent |
| 01/13/2005 | WO2005002482A1 Transdermal hormone delivery system: compositions and methods |
| 01/13/2005 | WO2004073654A3 A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained supression of gastric acid |
| 01/13/2005 | WO2004069876A3 Trimeric polypeptide construct to induce an enduring t cell response |
| 01/13/2005 | WO2004045633A3 Pharmaceutical composition comprising octreotide microparticles |
| 01/13/2005 | WO2004006958A8 Stable pharmaceutical composition comprising erythropoietin |
| 01/13/2005 | WO2003096983A3 Method of treating dyslipidemic disorders |
| 01/13/2005 | WO2003017943A3 Therapeutic compositions and methods for treating viral infection |
| 01/13/2005 | US20050010965 Method for producing tissue engineered meat for consumption |
| 01/13/2005 | US20050010196 Osmotic delivery system and method for decreasing start-up times for osmotic delivery systems |
| 01/13/2005 | US20050010060 Novel quinones as disease therapies |
| 01/13/2005 | US20050009988 Polymer derivatives having particular atom arrangements |
| 01/13/2005 | US20050009931 Dispersible pharmaceutical composition for treatment of mastitis and otic disorders |
| 01/13/2005 | US20050009918 Penetration enhancer; polysaccharide gum or polyacrylic acid thickener; aliphatic alcohol or ester or liquid polyol; water; and a buffer; relieves constriction of a blood vessel in vasospasm and restores blood flow; improving microcirculation in a replanted body part. |
| 01/13/2005 | US20050009908 Aqueous dispersion comprising stable nonoparticles of a water-insoluble active and an excipient like middle chain triglycerides (mct) |
| 01/13/2005 | US20050009857 Powder formulations containing tiotropium suitable for inhalation |
| 01/13/2005 | US20050009800 Solid, free-flowing dry extract of a natural mixture of conjugated equine estrogens that has been applied by spraying an aqueous solution of the mixture onto a powdered or granular microcrystalline cellulose support that may contain lactose |
| 01/13/2005 | US20050009791 Especially lysine, arginine, histidine, omithine and diaminobutyric acid; improved solubility for parenteral administration |
| 01/13/2005 | US20050009783 Adjust solubility; dissolving taxol and cyclodextrin compound in ethanol; stirring; heating |
| 01/13/2005 | US20050009741 Copolymer made by depolymerizing chitosan and acylating such as with glutaryl and propionyl groups; mixture with peptides such as buserelin, deslorelin, histrelin; ionic conjugate with parathyroid hormone |
| 01/13/2005 | US20050009740 Mixture of carrier, target peptide and immune response triggers |
| 01/13/2005 | US20050009739 Formulation strategies in stabilizing peptides in organic solvents and in dried states |
| 01/13/2005 | US20050009738 Interleukin with nucleic acid carrier |
| 01/13/2005 | US20050009735 Aqueous solution of insulin and surfactant; storage stability |
| 01/13/2005 | US20050009730 Sleep disorders; side effect reduction |
| 01/13/2005 | US20050009082 Beads, preparing method for the same, flow cytometer and program |
| 01/13/2005 | US20050009025 A soluble T cell receptor for use as diagnostic indicator of infection and autoimmune diseases |
| 01/13/2005 | US20050008746 Colorant for food and pharmaceuticals |
| 01/13/2005 | US20050008707 Nanoparticulate megestrol formulations |
| 01/13/2005 | US20050008706 Controlled agglomeration |
| 01/13/2005 | US20050008698 Base material for dry direct tableting comprising low-substituted hydroxypropyl cellulose |
| 01/13/2005 | US20050008697 Oral solid solution formulation of a poorly water-soluble active substance |
| 01/13/2005 | US20050008696 Using compression, thermal cycle molding, and thermal setting molding modules in continuous process |
| 01/13/2005 | US20050008694 Vaginally administratable progesterone-containing tablets and method for preparing same |
| 01/13/2005 | US20050008692 Compositions comprising pectin and ascorbic acid |
| 01/13/2005 | US20050008689 High efficiency encapsulation of charged therapeutic agents in lipid vesicles |
| 01/13/2005 | US20050008688 Oral administering; tablet with enteric coating; supplying drug to gastrointestinal systems |
| 01/13/2005 | US20050008679 synergistic efficacy; polar lipid supplement which contains antioxidants; soluble beta-glucan fiber; nutricine which enhances growth and/or strengthens the immune system; and a protein concentrate supplement such as whey protein concentrate |
| 01/13/2005 | US20050008677 Mixture of carrageenan, plasticizer and active materials; film forming; pH controlling |
| 01/13/2005 | US20050008650 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability |
| 01/13/2005 | US20050008648 Mutant kinase; anticancer agents; supplying to leukemia blastocytes; antibody which detects cell surface antigen; antiproliferative agent |
| 01/13/2005 | US20050008635 Humanized antibodies that bind to the antigen bound by antibody NR-LU-13 and their use in pretargeting methods |
| 01/13/2005 | US20050008634 Parenteral formulations of peptides for the treatment of systemic lupus erythematosus |
| 01/13/2005 | US20050008630 Preservation; nutrients; foods; using ascorbic and citric acid; oxidation resistance; by-product inhibition |